Brief: Glenmark Pharma Says Glenmark Pharma Inc., USA Launches Lacosamide Oral Solution
16/12/2024 03:21
Dec 16 (Reuters) - Glenmark Pharmaceuticals Ltd
GLEN.NS :
* GLENMARK PHARMACEUTICALS INC., USA LAUNCHES LACOSAMIDE
ORAL
SOLUTION, 10 MG/ML
Source text: ID:nBSE28f2Ds
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Glenmark Pharmaceuticals
See all newsBrief: Glenmark Pharma Says Unit Launches Ryaltris Nasal Spray In Brazil For Allergic Rhinitis
Brief: Glenmark Pharma US Unit Launches Calcium Gluconate Injection USP In Multiple Vial Sizes
India's Glenmark Pharma gains most in three weeks on US approval for Flonase nasal spray
Brief: Glenmark Pharma Gets U.S. FDA Approval For Fluticasone Propionate Nasal Spray 0.05 Mg/Spray
India's Glenmark Pharmaceuticals falls as brokerage flags softer-than-expected quarter